MAPT and Alzheimer disease: To address this issue, researchers have been exploring the use of multimodal imaging approaches that combine amyloid PET imaging with other biomarkers, such as tau PET imaging and structural MRI, to improve the accuracy of AD diagnosis and prognosis.